Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 76,610 |
|
|||||
| News | - | ||||||
| Day High | 155.825 | Low High |
|||||
| Day Low | 152.16 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Krystal Biotech Inc | KRYS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.22 | 0.14% | 153.34 | 11:10:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 152.16 | 152.16 | 155.825 | 153.12 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,011 | 76,610 | US$ 153.75 | US$ 11,778,460 | - | 82.09 - 189.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:10:11 | 1 | US$ 153.4853 | USD |
Krystal Biotech (KRYS) Options Flow Summary
Krystal Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.35B | 28.29M | - | 50.7M | 10.93M | 0.39 | 397.62 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Krystal Biotech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRYS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 163.18 | 165.785 | 152.16 | 156.52 | 212,015 | -9.84 | -6.03% |
| 1 Month | 174.96 | 182.51 | 152.16 | 168.12 | 246,189 | -21.62 | -12.36% |
| 3 Months | 114.77 | 189.97 | 107.50 | 158.83 | 391,730 | 38.57 | 33.61% |
| 6 Months | 116.76 | 189.97 | 93.95 | 136.55 | 356,961 | 36.58 | 31.33% |
| 1 Year | 83.84 | 189.97 | 82.09 | 127.45 | 324,594 | 69.50 | 82.90% |
| 3 Years | 81.01 | 189.97 | 38.8563 | 95.24 | 243,471 | 72.33 | 89.29% |
| 5 Years | 32.75 | 189.97 | 22.02 | 81.38 | 209,362 | 120.59 | 368.21% |
Krystal Biotech Description
| Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. |
